Hepatitis C: Epidemiology, management and treatment;État des connaissances sur l'hépatite C: Épidé miologie, prise en charge et traitements actuels

Bulletin de l'Academie Nationale de Medecine

Volumn 189, Issue 2, 2005, Pages 375-387

  Poupon, Raoul ^a   Henrion, Roger ^b   Bourel, M Michel ^b   Laverdant, Charles ^b   Chapuis, Yves ^b   Godeau, Pierre ^b   Denis, François ^b   Chadli, Amar ^b   Couturier, Daniel ^b   Ardaillou, Raymond ^b   Jaffiol, Claude ^b   Dreux, Claude ^b   Binet, Jacques Louis ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b NONE

Author keywords

Epidemiology; Hepatitis C; Interferon alpha 2A; Interferon alpha 2B; Liver cirrhosis; Ribavirin

Indexed keywords

ANTIVIRUS AGENT; VIRUS RNA;

BIOPSY; DRUG COMBINATION; GENETICS; GENOTYPE; HEPATITIS C; HUMAN; LIVER; PATHOLOGY; REVIEW;

ANTIVIRAL AGENTS; BIOPSY; DRUG THERAPY, COMBINATION; GENOTYPE; HEPATITIS C; HUMANS; LIVER; RNA, VIRAL;

EID: 22544470004     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33590-3     Document Type: Review

References (18)

1. SIMMONDS P. - Viral heterogeneity of the hepatitis C virus. J. Hepatol., 1999, 31, 54-60.
2. DHUMEAUX D. - Hepatitis C in France. Gastroenterol. Clin. Biol., 2002, 26, B133-7.
3. ROUDOT-THORAVAL F. - Modifications of epidemiological characteristics of hepatitis. Gastroenterol. Clin. Biol., 2002, 26, B138-43.
4. DELAROQUE-ASTAGNEAU E., CAMPESE C., BRONOWICKI JP., COUZIGOU P., GORIA O., GUYADER D. et al. - Surveillance de l'hépatite C à l'échelon national à partir des pôles de référence volontaires, 2000-2001. BEH, 2003, no 16-17.
5. PAWLOTSKY JM. - Molecular diagnosis of viral hepatitis. Gastroenterology, 2003, 122, 1554-1568.
6. PAWLOTSKY JM. - Use and interpretation of virological tests for hepatitis C. Hepatology, 2002, 36, S65-S73.
7. BEDOSSA P., POYNARD T. - An algorithm for the grading of activity in chronic hepatitis C. The Metavir Cooperative Study Group. Hepatology, 1996, 24, 289-293.
8. ISHAK K., BAPTISTA A., BIANCHI L., CALLEA F., DE GROOTE J., GUDAT F., DENK H. et al. - Histological grading and staging of chronic hepatitis. J. Hepatol., 1995, 22, 696-699.
9. STRADER DB., WRIGHT T., THOMAS DL., SEEFF LB. - Diagnosis, management and treatment of hepatitis C. - Hepatology, 2004, 39, 1147-71.
10. FRIED MW., SHIFFMAN ML., REDDY KR., SMITH C., MARINOS G., GONCALES FL. Jr et al. - Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med., 2002, 347, 975-982.
11. HADZIYANNIS SJ., SETTE H., MORGAN TR., BALAN V., DIAGO M., MARCELLIN P. et al. - Peginterferon alfa-2a (40 kilodaltons) and ribovirin combination therapy in chronic hepatitis C: randomized study of the effect of treatment duration and ribavirin dose. Ann. Intern. Med., 2004, 140, 346-355.
12. DHUMEAUX D., MARCELLIN P., LEREBOURS E. - Treatment of hepatitis C. The 2002 French consensus. Gut, 2003, 52, 1784-7.
13. ALBERTI A., BENVEGNU L. - Management of hepatitis C. J. Hepatol., 2003, 38, S104-18.
14. JONAS MM. - Children with hepatitis C. Hepatology, 2002, 36, S173-S178.
15. SERFATY L., COSTAGLIOLA D., WENDUM D., PICARD O., MEYOHAS MC., GIRARD LEBAS J. et al. - Impact of early-untreated HIV infection on chronic hepatitis intravenous drug users : a case-control study. AIDS, 2001, 15, 2011-6.
16. SULKOWSKI MS., THOMAS DL., CHAISSON RE., MOORE RD. - Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA, 2000, 283, 74-80.
17. MEYERS CM., SEEFF LB., STEHMAN-BREEN O., HOOFNAGLE JH. - Hepatitis C and renal disease: an update. Am. J. Kidney. Dis., 2003, 42, 631-657.
18. FURUSYO N., HAYASHI J., KANAMOTO-TANAKA Y., ARIYAMA I., ETOH Y., SHIGEMATSU M. et al. - Liver damage in hemodialysis patients with hepatitis C virus viremia : a prospective 10-year study. Dig. Dis. Sci., 2000, 45, 2221-2228.